Related content

Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients

By Chim C. S.   Sim J. P.   Chan C. C.   Kho B. C.   Chan J. C.   Wong L. G.   Law M.   Liang R.   Kwong Y. L.  

Hematology, Vol. 15, Iss. 4, 2010-08 ,pp. : 187-192

Maney Publishing

Access to resources Recommend Favorite

JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate

By Lee Yoo  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 804-807

Springer Publishing Company

Access to resources Recommend Favorite

Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis

By Garcés-Eisele Javier   González-Carrillo Martha L.   Reyes-Núñez Virginia   Ruiz-Argüelles Guillermo J.  

Hematology, Vol. 13, Iss. 4, 2008-08 ,pp. : 244-246

Maney Publishing

Access to resources Recommend Favorite

High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden

By Larsen Thomas Stauffer   Pallisgaard Niels   Møller Michael Boe   Hasselbalch Hans Carl  

Hematology, Vol. 13, Iss. 2, 2008-04 ,pp. : 71-76

Maney Publishing

Access to resources Recommend Favorite